nodes	percent_of_prediction	percent_of_DWPC	metapath
Thiabendazole—CYP1A1—lung cancer	0.532	1	CbGaD
Thiabendazole—CYP1A1—Gefitinib—lung cancer	0.137	0.489	CbGbCtD
Thiabendazole—CYP1A1—Erlotinib—lung cancer	0.081	0.289	CbGbCtD
Thiabendazole—CYP1A2—Erlotinib—lung cancer	0.0362	0.129	CbGbCtD
Thiabendazole—CYP1A2—Etoposide—lung cancer	0.0262	0.0934	CbGbCtD
Thiabendazole—Lansoprazole—ABCG2—lung cancer	0.00151	0.455	CrCbGaD
Thiabendazole—Lansoprazole—CYP1A1—lung cancer	0.00118	0.356	CrCbGaD
Thiabendazole—Lansoprazole—ABCB1—lung cancer	0.000627	0.189	CrCbGaD
Thiabendazole—Hypotension—Vinorelbine—lung cancer	0.000311	0.00245	CcSEcCtD
Thiabendazole—Hepatic failure—Methotrexate—lung cancer	0.000309	0.00243	CcSEcCtD
Thiabendazole—Abdominal pain—Topotecan—lung cancer	0.000307	0.00242	CcSEcCtD
Thiabendazole—Abdominal pain—Erlotinib—lung cancer	0.000304	0.00239	CcSEcCtD
Thiabendazole—Erythema multiforme—Etoposide—lung cancer	0.000304	0.00239	CcSEcCtD
Thiabendazole—Visual impairment—Paclitaxel—lung cancer	0.000303	0.00239	CcSEcCtD
Thiabendazole—Leukopenia—Irinotecan—lung cancer	0.000301	0.00237	CcSEcCtD
Thiabendazole—Flushing—Etoposide—lung cancer	0.000298	0.00234	CcSEcCtD
Thiabendazole—Erythema multiforme—Paclitaxel—lung cancer	0.000298	0.00234	CcSEcCtD
Thiabendazole—Hypersensitivity—Vinblastine—lung cancer	0.000295	0.00232	CcSEcCtD
Thiabendazole—Stevens-Johnson syndrome—Docetaxel—lung cancer	0.000295	0.00232	CcSEcCtD
Thiabendazole—Tinnitus—Paclitaxel—lung cancer	0.000293	0.00231	CcSEcCtD
Thiabendazole—Leukopenia—Gemcitabine—lung cancer	0.000293	0.00231	CcSEcCtD
Thiabendazole—Flushing—Paclitaxel—lung cancer	0.000292	0.0023	CcSEcCtD
Thiabendazole—Jaundice—Docetaxel—lung cancer	0.00029	0.00228	CcSEcCtD
Thiabendazole—Decreased appetite—Vinorelbine—lung cancer	0.000289	0.00227	CcSEcCtD
Thiabendazole—Chills—Etoposide—lung cancer	0.000288	0.00227	CcSEcCtD
Thiabendazole—Vision blurred—Cisplatin—lung cancer	0.000287	0.00226	CcSEcCtD
Thiabendazole—Asthenia—Vinblastine—lung cancer	0.000287	0.00226	CcSEcCtD
Thiabendazole—Fatigue—Vinorelbine—lung cancer	0.000287	0.00226	CcSEcCtD
Thiabendazole—Hypersensitivity—Topotecan—lung cancer	0.000286	0.00225	CcSEcCtD
Thiabendazole—Chills—Paclitaxel—lung cancer	0.000282	0.00222	CcSEcCtD
Thiabendazole—Lymphadenopathy—Doxorubicin—lung cancer	0.000282	0.00222	CcSEcCtD
Thiabendazole—Asthenia—Topotecan—lung cancer	0.000279	0.00219	CcSEcCtD
Thiabendazole—Confusional state—Irinotecan—lung cancer	0.000276	0.00218	CcSEcCtD
Thiabendazole—Asthenia—Erlotinib—lung cancer	0.000276	0.00217	CcSEcCtD
Thiabendazole—Pruritus—Topotecan—lung cancer	0.000275	0.00216	CcSEcCtD
Thiabendazole—Anaphylactic shock—Irinotecan—lung cancer	0.000274	0.00216	CcSEcCtD
Thiabendazole—Feeling abnormal—Vinorelbine—lung cancer	0.000274	0.00216	CcSEcCtD
Thiabendazole—Diarrhoea—Vinblastine—lung cancer	0.000274	0.00215	CcSEcCtD
Thiabendazole—Leukopenia—Cisplatin—lung cancer	0.000273	0.00215	CcSEcCtD
Thiabendazole—Pruritus—Erlotinib—lung cancer	0.000272	0.00214	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Vinorelbine—lung cancer	0.000272	0.00214	CcSEcCtD
Thiabendazole—Hepatic failure—Doxorubicin—lung cancer	0.000268	0.00211	CcSEcCtD
Thiabendazole—Anaphylactic shock—Gemcitabine—lung cancer	0.000267	0.0021	CcSEcCtD
Thiabendazole—Diarrhoea—Topotecan—lung cancer	0.000266	0.00209	CcSEcCtD
Thiabendazole—Hypoaesthesia—Docetaxel—lung cancer	0.000265	0.00209	CcSEcCtD
Thiabendazole—Dizziness—Vinblastine—lung cancer	0.000265	0.00208	CcSEcCtD
Thiabendazole—Convulsion—Cisplatin—lung cancer	0.000264	0.00208	CcSEcCtD
Thiabendazole—Diarrhoea—Erlotinib—lung cancer	0.000263	0.00207	CcSEcCtD
Thiabendazole—Abdominal pain—Vinorelbine—lung cancer	0.000263	0.00207	CcSEcCtD
Thiabendazole—Anorexia—Irinotecan—lung cancer	0.000261	0.00206	CcSEcCtD
Thiabendazole—Vision blurred—Paclitaxel—lung cancer	0.000258	0.00203	CcSEcCtD
Thiabendazole—Visual impairment—Docetaxel—lung cancer	0.000257	0.00202	CcSEcCtD
Thiabendazole—Dizziness—Topotecan—lung cancer	0.000257	0.00202	CcSEcCtD
Thiabendazole—Hypotension—Irinotecan—lung cancer	0.000256	0.00202	CcSEcCtD
Thiabendazole—Anorexia—Gemcitabine—lung cancer	0.000255	0.002	CcSEcCtD
Thiabendazole—Vomiting—Vinblastine—lung cancer	0.000254	0.002	CcSEcCtD
Thiabendazole—Dizziness—Erlotinib—lung cancer	0.000254	0.002	CcSEcCtD
Thiabendazole—Erythema multiforme—Docetaxel—lung cancer	0.000252	0.00199	CcSEcCtD
Thiabendazole—Headache—Vinblastine—lung cancer	0.000251	0.00197	CcSEcCtD
Thiabendazole—Angioedema—Paclitaxel—lung cancer	0.00025	0.00197	CcSEcCtD
Thiabendazole—Leukopenia—Etoposide—lung cancer	0.00025	0.00197	CcSEcCtD
Thiabendazole—Hypotension—Gemcitabine—lung cancer	0.00025	0.00196	CcSEcCtD
Thiabendazole—Anaphylactic shock—Cisplatin—lung cancer	0.000249	0.00196	CcSEcCtD
Thiabendazole—Flushing—Docetaxel—lung cancer	0.000248	0.00195	CcSEcCtD
Thiabendazole—Vomiting—Topotecan—lung cancer	0.000247	0.00194	CcSEcCtD
Thiabendazole—Leukopenia—Paclitaxel—lung cancer	0.000245	0.00193	CcSEcCtD
Thiabendazole—Rash—Topotecan—lung cancer	0.000245	0.00193	CcSEcCtD
Thiabendazole—Hypersensitivity—Vinorelbine—lung cancer	0.000245	0.00193	CcSEcCtD
Thiabendazole—Dermatitis—Topotecan—lung cancer	0.000245	0.00193	CcSEcCtD
Thiabendazole—Vomiting—Erlotinib—lung cancer	0.000244	0.00192	CcSEcCtD
Thiabendazole—Somnolence—Irinotecan—lung cancer	0.000244	0.00192	CcSEcCtD
Thiabendazole—Headache—Topotecan—lung cancer	0.000243	0.00192	CcSEcCtD
Thiabendazole—Rash—Erlotinib—lung cancer	0.000242	0.00191	CcSEcCtD
Thiabendazole—Dermatitis—Erlotinib—lung cancer	0.000242	0.00191	CcSEcCtD
Thiabendazole—Convulsion—Etoposide—lung cancer	0.000242	0.00191	CcSEcCtD
Thiabendazole—Dyspepsia—Irinotecan—lung cancer	0.000241	0.0019	CcSEcCtD
Thiabendazole—Headache—Erlotinib—lung cancer	0.000241	0.0019	CcSEcCtD
Thiabendazole—Chills—Docetaxel—lung cancer	0.000239	0.00188	CcSEcCtD
Thiabendazole—Asthenia—Vinorelbine—lung cancer	0.000239	0.00188	CcSEcCtD
Thiabendazole—Decreased appetite—Irinotecan—lung cancer	0.000238	0.00188	CcSEcCtD
Thiabendazole—Nausea—Vinblastine—lung cancer	0.000238	0.00187	CcSEcCtD
Thiabendazole—Somnolence—Gemcitabine—lung cancer	0.000237	0.00187	CcSEcCtD
Thiabendazole—Convulsion—Paclitaxel—lung cancer	0.000237	0.00187	CcSEcCtD
Thiabendazole—Anorexia—Cisplatin—lung cancer	0.000237	0.00187	CcSEcCtD
Thiabendazole—Fatigue—Irinotecan—lung cancer	0.000236	0.00186	CcSEcCtD
Thiabendazole—Pruritus—Vinorelbine—lung cancer	0.000235	0.00185	CcSEcCtD
Thiabendazole—Hypotension—Cisplatin—lung cancer	0.000233	0.00183	CcSEcCtD
Thiabendazole—Decreased appetite—Gemcitabine—lung cancer	0.000232	0.00183	CcSEcCtD
Thiabendazole—Nausea—Topotecan—lung cancer	0.000231	0.00182	CcSEcCtD
Thiabendazole—Fatigue—Gemcitabine—lung cancer	0.00023	0.00181	CcSEcCtD
Thiabendazole—Confusional state—Etoposide—lung cancer	0.00023	0.00181	CcSEcCtD
Thiabendazole—Nausea—Erlotinib—lung cancer	0.000228	0.0018	CcSEcCtD
Thiabendazole—Anaphylactic shock—Etoposide—lung cancer	0.000228	0.0018	CcSEcCtD
Thiabendazole—Diarrhoea—Vinorelbine—lung cancer	0.000227	0.00179	CcSEcCtD
Thiabendazole—Feeling abnormal—Irinotecan—lung cancer	0.000226	0.00178	CcSEcCtD
Thiabendazole—Confusional state—Paclitaxel—lung cancer	0.000225	0.00177	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Irinotecan—lung cancer	0.000224	0.00176	CcSEcCtD
Thiabendazole—Anaphylactic shock—Paclitaxel—lung cancer	0.000224	0.00176	CcSEcCtD
Thiabendazole—Feeling abnormal—Gemcitabine—lung cancer	0.00022	0.00173	CcSEcCtD
Thiabendazole—Dizziness—Vinorelbine—lung cancer	0.00022	0.00173	CcSEcCtD
Thiabendazole—Anorexia—Etoposide—lung cancer	0.000217	0.00171	CcSEcCtD
Thiabendazole—Abdominal pain—Irinotecan—lung cancer	0.000217	0.00171	CcSEcCtD
Thiabendazole—Decreased appetite—Cisplatin—lung cancer	0.000216	0.0017	CcSEcCtD
Thiabendazole—Drowsiness—Methotrexate—lung cancer	0.000214	0.00169	CcSEcCtD
Thiabendazole—Anorexia—Paclitaxel—lung cancer	0.000213	0.00168	CcSEcCtD
Thiabendazole—Hypotension—Etoposide—lung cancer	0.000213	0.00168	CcSEcCtD
Thiabendazole—Stevens-Johnson syndrome—Methotrexate—lung cancer	0.000212	0.00167	CcSEcCtD
Thiabendazole—Vomiting—Vinorelbine—lung cancer	0.000211	0.00166	CcSEcCtD
Thiabendazole—Rash—Vinorelbine—lung cancer	0.00021	0.00165	CcSEcCtD
Thiabendazole—Dermatitis—Vinorelbine—lung cancer	0.000209	0.00165	CcSEcCtD
Thiabendazole—Hypotension—Paclitaxel—lung cancer	0.000209	0.00164	CcSEcCtD
Thiabendazole—Headache—Vinorelbine—lung cancer	0.000208	0.00164	CcSEcCtD
Thiabendazole—Leukopenia—Docetaxel—lung cancer	0.000208	0.00164	CcSEcCtD
Thiabendazole—Feeling abnormal—Cisplatin—lung cancer	0.000205	0.00161	CcSEcCtD
Thiabendazole—Haematuria—Methotrexate—lung cancer	0.000204	0.00161	CcSEcCtD
Thiabendazole—Somnolence—Etoposide—lung cancer	0.000203	0.0016	CcSEcCtD
Thiabendazole—Hypersensitivity—Irinotecan—lung cancer	0.000202	0.00159	CcSEcCtD
Thiabendazole—Convulsion—Docetaxel—lung cancer	0.000201	0.00158	CcSEcCtD
Thiabendazole—Somnolence—Paclitaxel—lung cancer	0.000199	0.00156	CcSEcCtD
Thiabendazole—Decreased appetite—Etoposide—lung cancer	0.000198	0.00156	CcSEcCtD
Thiabendazole—Nausea—Vinorelbine—lung cancer	0.000197	0.00155	CcSEcCtD
Thiabendazole—Dyspepsia—Paclitaxel—lung cancer	0.000197	0.00155	CcSEcCtD
Thiabendazole—Asthenia—Irinotecan—lung cancer	0.000197	0.00155	CcSEcCtD
Thiabendazole—Fatigue—Etoposide—lung cancer	0.000197	0.00155	CcSEcCtD
Thiabendazole—Decreased appetite—Paclitaxel—lung cancer	0.000194	0.00153	CcSEcCtD
Thiabendazole—Fatigue—Paclitaxel—lung cancer	0.000193	0.00152	CcSEcCtD
Thiabendazole—Asthenia—Gemcitabine—lung cancer	0.000192	0.00151	CcSEcCtD
Thiabendazole—Confusional state—Docetaxel—lung cancer	0.000191	0.0015	CcSEcCtD
Thiabendazole—Anaphylactic shock—Docetaxel—lung cancer	0.00019	0.00149	CcSEcCtD
Thiabendazole—Pruritus—Gemcitabine—lung cancer	0.000189	0.00149	CcSEcCtD
Thiabendazole—Feeling abnormal—Etoposide—lung cancer	0.000188	0.00148	CcSEcCtD
Thiabendazole—Hyperglycaemia—Doxorubicin—lung cancer	0.000188	0.00148	CcSEcCtD
Thiabendazole—Diarrhoea—Irinotecan—lung cancer	0.000188	0.00148	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Etoposide—lung cancer	0.000187	0.00147	CcSEcCtD
Thiabendazole—Drowsiness—Doxorubicin—lung cancer	0.000185	0.00146	CcSEcCtD
Thiabendazole—Visual impairment—Methotrexate—lung cancer	0.000185	0.00146	CcSEcCtD
Thiabendazole—Feeling abnormal—Paclitaxel—lung cancer	0.000184	0.00145	CcSEcCtD
Thiabendazole—Stevens-Johnson syndrome—Doxorubicin—lung cancer	0.000184	0.00145	CcSEcCtD
Thiabendazole—Hypersensitivity—Cisplatin—lung cancer	0.000183	0.00144	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Paclitaxel—lung cancer	0.000183	0.00144	CcSEcCtD
Thiabendazole—Diarrhoea—Gemcitabine—lung cancer	0.000183	0.00144	CcSEcCtD
Thiabendazole—Erythema multiforme—Methotrexate—lung cancer	0.000182	0.00143	CcSEcCtD
Thiabendazole—Dizziness—Irinotecan—lung cancer	0.000181	0.00143	CcSEcCtD
Thiabendazole—Jaundice—Doxorubicin—lung cancer	0.000181	0.00142	CcSEcCtD
Thiabendazole—Anorexia—Docetaxel—lung cancer	0.000181	0.00142	CcSEcCtD
Thiabendazole—Abdominal pain—Etoposide—lung cancer	0.00018	0.00142	CcSEcCtD
Thiabendazole—Tinnitus—Methotrexate—lung cancer	0.000179	0.00141	CcSEcCtD
Thiabendazole—Asthenia—Cisplatin—lung cancer	0.000179	0.00141	CcSEcCtD
Thiabendazole—Hypotension—Docetaxel—lung cancer	0.000177	0.00139	CcSEcCtD
Thiabendazole—Haematuria—Doxorubicin—lung cancer	0.000177	0.00139	CcSEcCtD
Thiabendazole—Abdominal pain—Paclitaxel—lung cancer	0.000177	0.00139	CcSEcCtD
Thiabendazole—Vomiting—Irinotecan—lung cancer	0.000174	0.00137	CcSEcCtD
Thiabendazole—Rash—Irinotecan—lung cancer	0.000173	0.00136	CcSEcCtD
Thiabendazole—Dermatitis—Irinotecan—lung cancer	0.000173	0.00136	CcSEcCtD
Thiabendazole—Chills—Methotrexate—lung cancer	0.000173	0.00136	CcSEcCtD
Thiabendazole—Headache—Irinotecan—lung cancer	0.000172	0.00135	CcSEcCtD
Thiabendazole—Diarrhoea—Cisplatin—lung cancer	0.00017	0.00134	CcSEcCtD
Thiabendazole—Vomiting—Gemcitabine—lung cancer	0.00017	0.00134	CcSEcCtD
Thiabendazole—Somnolence—Docetaxel—lung cancer	0.000169	0.00133	CcSEcCtD
Thiabendazole—Rash—Gemcitabine—lung cancer	0.000168	0.00133	CcSEcCtD
Thiabendazole—Dermatitis—Gemcitabine—lung cancer	0.000168	0.00132	CcSEcCtD
Thiabendazole—Hypersensitivity—Etoposide—lung cancer	0.000168	0.00132	CcSEcCtD
Thiabendazole—Headache—Gemcitabine—lung cancer	0.000167	0.00132	CcSEcCtD
Thiabendazole—Dyspepsia—Docetaxel—lung cancer	0.000167	0.00131	CcSEcCtD
Thiabendazole—Hypoaesthesia—Doxorubicin—lung cancer	0.000166	0.0013	CcSEcCtD
Thiabendazole—Decreased appetite—Docetaxel—lung cancer	0.000165	0.0013	CcSEcCtD
Thiabendazole—Hypersensitivity—Paclitaxel—lung cancer	0.000165	0.0013	CcSEcCtD
Thiabendazole—Asthenia—Etoposide—lung cancer	0.000164	0.00129	CcSEcCtD
Thiabendazole—Fatigue—Docetaxel—lung cancer	0.000163	0.00129	CcSEcCtD
Thiabendazole—Nausea—Irinotecan—lung cancer	0.000163	0.00128	CcSEcCtD
Thiabendazole—Pruritus—Etoposide—lung cancer	0.000161	0.00127	CcSEcCtD
Thiabendazole—Visual impairment—Doxorubicin—lung cancer	0.00016	0.00126	CcSEcCtD
Thiabendazole—Asthenia—Paclitaxel—lung cancer	0.00016	0.00126	CcSEcCtD
Thiabendazole—Nausea—Gemcitabine—lung cancer	0.000159	0.00125	CcSEcCtD
Thiabendazole—Vomiting—Cisplatin—lung cancer	0.000158	0.00125	CcSEcCtD
Thiabendazole—Pruritus—Paclitaxel—lung cancer	0.000158	0.00125	CcSEcCtD
Thiabendazole—Vision blurred—Methotrexate—lung cancer	0.000158	0.00124	CcSEcCtD
Thiabendazole—Erythema multiforme—Doxorubicin—lung cancer	0.000157	0.00124	CcSEcCtD
Thiabendazole—Rash—Cisplatin—lung cancer	0.000157	0.00124	CcSEcCtD
Thiabendazole—Dermatitis—Cisplatin—lung cancer	0.000157	0.00123	CcSEcCtD
Thiabendazole—Feeling abnormal—Docetaxel—lung cancer	0.000156	0.00123	CcSEcCtD
Thiabendazole—Diarrhoea—Etoposide—lung cancer	0.000156	0.00123	CcSEcCtD
Thiabendazole—Tinnitus—Doxorubicin—lung cancer	0.000155	0.00122	CcSEcCtD
Thiabendazole—CYP1A1—Metapathway biotransformation—UGT1A1—lung cancer	0.000155	0.00268	CbGpPWpGaD
Thiabendazole—Gastrointestinal pain—Docetaxel—lung cancer	0.000155	0.00122	CcSEcCtD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—COL4A3BP—lung cancer	0.000155	0.00268	CbGpPWpGaD
Thiabendazole—Flushing—Doxorubicin—lung cancer	0.000155	0.00122	CcSEcCtD
Thiabendazole—CYP1A2—Phase 1 - Functionalization of compounds—CYP2A6—lung cancer	0.000154	0.00266	CbGpPWpGaD
Thiabendazole—CYP1A2—Metapathway biotransformation—GSTM2—lung cancer	0.000154	0.00265	CbGpPWpGaD
Thiabendazole—Diarrhoea—Paclitaxel—lung cancer	0.000153	0.0012	CcSEcCtD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—lung cancer	0.000152	0.00263	CbGpPWpGaD
Thiabendazole—Dizziness—Etoposide—lung cancer	0.000151	0.00119	CcSEcCtD
Thiabendazole—Abdominal pain—Docetaxel—lung cancer	0.00015	0.00118	CcSEcCtD
Thiabendazole—Leukopenia—Methotrexate—lung cancer	0.00015	0.00118	CcSEcCtD
Thiabendazole—Chills—Doxorubicin—lung cancer	0.000149	0.00118	CcSEcCtD
Thiabendazole—Dizziness—Paclitaxel—lung cancer	0.000148	0.00116	CcSEcCtD
Thiabendazole—Nausea—Cisplatin—lung cancer	0.000148	0.00116	CcSEcCtD
Thiabendazole—CYP1A2—Phase II conjugation—HPGDS—lung cancer	0.000146	0.00252	CbGpPWpGaD
Thiabendazole—Convulsion—Methotrexate—lung cancer	0.000145	0.00114	CcSEcCtD
Thiabendazole—Vomiting—Etoposide—lung cancer	0.000145	0.00114	CcSEcCtD
Thiabendazole—Rash—Etoposide—lung cancer	0.000144	0.00113	CcSEcCtD
Thiabendazole—Dermatitis—Etoposide—lung cancer	0.000144	0.00113	CcSEcCtD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—lung cancer	0.000144	0.00248	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—lung cancer	0.000144	0.00248	CbGpPWpGaD
Thiabendazole—CYP1A2—Tryptophan metabolism—CYP1A1—lung cancer	0.000144	0.00248	CbGpPWpGaD
Thiabendazole—Headache—Etoposide—lung cancer	0.000143	0.00112	CcSEcCtD
Thiabendazole—Vomiting—Paclitaxel—lung cancer	0.000142	0.00112	CcSEcCtD
Thiabendazole—CYP1A2—Phase II conjugation—GSTT1—lung cancer	0.000141	0.00244	CbGpPWpGaD
Thiabendazole—Rash—Paclitaxel—lung cancer	0.000141	0.00111	CcSEcCtD
Thiabendazole—Dermatitis—Paclitaxel—lung cancer	0.000141	0.00111	CcSEcCtD
Thiabendazole—CYP1A2—Biological oxidations—CYP2A7—lung cancer	0.000141	0.00243	CbGpPWpGaD
Thiabendazole—Headache—Paclitaxel—lung cancer	0.00014	0.0011	CcSEcCtD
Thiabendazole—CYP1A2—Phase II conjugation—GCLC—lung cancer	0.00014	0.00242	CbGpPWpGaD
Thiabendazole—Hypersensitivity—Docetaxel—lung cancer	0.00014	0.0011	CcSEcCtD
Thiabendazole—CYP1A2—Metapathway biotransformation—CYP2A7—lung cancer	0.000139	0.0024	CbGpPWpGaD
Thiabendazole—CYP1A1—Tryptophan metabolism—MDM2—lung cancer	0.000139	0.0024	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—RAF1—lung cancer	0.000138	0.00239	CbGpPWpGaD
Thiabendazole—Confusional state—Methotrexate—lung cancer	0.000138	0.00108	CcSEcCtD
Thiabendazole—Anaphylactic shock—Methotrexate—lung cancer	0.000137	0.00108	CcSEcCtD
Thiabendazole—Vision blurred—Doxorubicin—lung cancer	0.000137	0.00108	CcSEcCtD
Thiabendazole—Asthenia—Docetaxel—lung cancer	0.000136	0.00107	CcSEcCtD
Thiabendazole—CYP1A1—Cytochrome P450 - arranged by substrate type—POMC—lung cancer	0.000136	0.00235	CbGpPWpGaD
Thiabendazole—Nausea—Etoposide—lung cancer	0.000135	0.00107	CcSEcCtD
Thiabendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—NCOA3—lung cancer	0.000135	0.00234	CbGpPWpGaD
Thiabendazole—CYP1A2—Arachidonic acid metabolism—CYP1A1—lung cancer	0.000134	0.00232	CbGpPWpGaD
Thiabendazole—Pruritus—Docetaxel—lung cancer	0.000134	0.00106	CcSEcCtD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—lung cancer	0.000134	0.00231	CbGpPWpGaD
Thiabendazole—CYP1A1—Biological oxidations—HPGDS—lung cancer	0.000134	0.00231	CbGpPWpGaD
Thiabendazole—Nausea—Paclitaxel—lung cancer	0.000133	0.00105	CcSEcCtD
Thiabendazole—CYP1A2—Phase 1 - Functionalization of compounds—CYP2E1—lung cancer	0.000131	0.00226	CbGpPWpGaD
Thiabendazole—Anorexia—Methotrexate—lung cancer	0.00013	0.00102	CcSEcCtD
Thiabendazole—CYP1A1—Biological oxidations—GSTT1—lung cancer	0.00013	0.00224	CbGpPWpGaD
Thiabendazole—Leukopenia—Doxorubicin—lung cancer	0.00013	0.00102	CcSEcCtD
Thiabendazole—Diarrhoea—Docetaxel—lung cancer	0.00013	0.00102	CcSEcCtD
Thiabendazole—CYP1A1—Biological oxidations—GCLC—lung cancer	0.000128	0.00222	CbGpPWpGaD
Thiabendazole—CYP1A1—Biological oxidations—CYP2A6—lung cancer	0.000128	0.00222	CbGpPWpGaD
Thiabendazole—Hypotension—Methotrexate—lung cancer	0.000128	0.001	CcSEcCtD
Thiabendazole—Convulsion—Doxorubicin—lung cancer	0.000126	0.000988	CcSEcCtD
Thiabendazole—CYP1A2—Biological oxidations—GSTA3—lung cancer	0.000126	0.00217	CbGpPWpGaD
Thiabendazole—Dizziness—Docetaxel—lung cancer	0.000125	0.000987	CcSEcCtD
Thiabendazole—CYP1A1—Arachidonic acid metabolism—PTGS2—lung cancer	0.000125	0.00216	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—lung cancer	0.000124	0.00214	CbGpPWpGaD
Thiabendazole—CYP1A2—Metapathway biotransformation—GSTA3—lung cancer	0.000124	0.00214	CbGpPWpGaD
Thiabendazole—Somnolence—Methotrexate—lung cancer	0.000121	0.000956	CcSEcCtD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—JUN—lung cancer	0.000121	0.00209	CbGpPWpGaD
Thiabendazole—Vomiting—Docetaxel—lung cancer	0.000121	0.000949	CcSEcCtD
Thiabendazole—Dyspepsia—Methotrexate—lung cancer	0.00012	0.000946	CcSEcCtD
Thiabendazole—Rash—Docetaxel—lung cancer	0.00012	0.000941	CcSEcCtD
Thiabendazole—Dermatitis—Docetaxel—lung cancer	0.000119	0.00094	CcSEcCtD
Thiabendazole—Confusional state—Doxorubicin—lung cancer	0.000119	0.000939	CcSEcCtD
Thiabendazole—Decreased appetite—Methotrexate—lung cancer	0.000119	0.000935	CcSEcCtD
Thiabendazole—Headache—Docetaxel—lung cancer	0.000119	0.000935	CcSEcCtD
Thiabendazole—Anaphylactic shock—Doxorubicin—lung cancer	0.000118	0.000931	CcSEcCtD
Thiabendazole—Fatigue—Methotrexate—lung cancer	0.000118	0.000927	CcSEcCtD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—PLBD1—lung cancer	0.000117	0.00203	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1A—lung cancer	0.000117	0.00202	CbGpPWpGaD
Thiabendazole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—lung cancer	0.000116	0.00201	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—GSTA4—lung cancer	0.000115	0.00198	CbGpPWpGaD
Thiabendazole—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—lung cancer	0.000115	0.00198	CbGpPWpGaD
Thiabendazole—CYP1A2—Metapathway biotransformation—GSTA4—lung cancer	0.000113	0.00196	CbGpPWpGaD
Thiabendazole—Anorexia—Doxorubicin—lung cancer	0.000113	0.000887	CcSEcCtD
Thiabendazole—Nausea—Docetaxel—lung cancer	0.000113	0.000886	CcSEcCtD
Thiabendazole—Feeling abnormal—Methotrexate—lung cancer	0.000113	0.000886	CcSEcCtD
Thiabendazole—CYP1A2—Biological oxidations—GSTA2—lung cancer	0.000112	0.00193	CbGpPWpGaD
Thiabendazole—Gastrointestinal pain—Methotrexate—lung cancer	0.000112	0.000879	CcSEcCtD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—EP300—lung cancer	0.000111	0.00192	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EP300—lung cancer	0.000111	0.00192	CbGpPWpGaD
Thiabendazole—Hypotension—Doxorubicin—lung cancer	0.000111	0.00087	CcSEcCtD
Thiabendazole—CYP1A1—Phase 1 - Functionalization of compounds—POMC—lung cancer	0.00011	0.0019	CbGpPWpGaD
Thiabendazole—CYP1A1—Biological oxidations—CYP2E1—lung cancer	0.000109	0.00189	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—SRC—lung cancer	0.000108	0.00187	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—SRC—lung cancer	0.000108	0.00187	CbGpPWpGaD
Thiabendazole—Abdominal pain—Methotrexate—lung cancer	0.000108	0.00085	CcSEcCtD
Thiabendazole—CYP1A2—Biological oxidations—GSTA1—lung cancer	0.000108	0.00187	CbGpPWpGaD
Thiabendazole—CYP1A1—Metapathway biotransformation—CYP2E1—lung cancer	0.000108	0.00186	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—lung cancer	0.000105	0.00182	CbGpPWpGaD
Thiabendazole—Somnolence—Doxorubicin—lung cancer	0.000105	0.000828	CcSEcCtD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—NRAS—lung cancer	0.000104	0.0018	CbGpPWpGaD
Thiabendazole—Dyspepsia—Doxorubicin—lung cancer	0.000104	0.00082	CcSEcCtD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—RB1—lung cancer	0.000104	0.00179	CbGpPWpGaD
Thiabendazole—Decreased appetite—Doxorubicin—lung cancer	0.000103	0.000809	CcSEcCtD
Thiabendazole—Fatigue—Doxorubicin—lung cancer	0.000102	0.000803	CcSEcCtD
Thiabendazole—CYP1A2—Metapathway biotransformation—AKR1C1—lung cancer	0.000102	0.00176	CbGpPWpGaD
Thiabendazole—Hypersensitivity—Methotrexate—lung cancer	0.000101	0.000792	CcSEcCtD
Thiabendazole—CYP1A2—Biological oxidations—UGT1A1—lung cancer	0.0001	0.00173	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—MAP2K1—lung cancer	9.95e-05	0.00172	CbGpPWpGaD
Thiabendazole—CYP1A2—Metapathway biotransformation—UGT1A1—lung cancer	9.9e-05	0.00171	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—COL4A3BP—lung cancer	9.87e-05	0.00171	CbGpPWpGaD
Thiabendazole—CYP1A2—Phase II conjugation—GSTP1—lung cancer	9.8e-05	0.00169	CbGpPWpGaD
Thiabendazole—Asthenia—Methotrexate—lung cancer	9.8e-05	0.000771	CcSEcCtD
Thiabendazole—Feeling abnormal—Doxorubicin—lung cancer	9.75e-05	0.000767	CcSEcCtD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—MYC—lung cancer	9.7e-05	0.00168	CbGpPWpGaD
Thiabendazole—Gastrointestinal pain—Doxorubicin—lung cancer	9.67e-05	0.000761	CcSEcCtD
Thiabendazole—Pruritus—Methotrexate—lung cancer	9.67e-05	0.000761	CcSEcCtD
Thiabendazole—CYP1A1—PPARA activates gene expression—APOA1—lung cancer	9.61e-05	0.00166	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—lung cancer	9.49e-05	0.00164	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—lung cancer	9.49e-05	0.00164	CbGpPWpGaD
Thiabendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—APOA1—lung cancer	9.41e-05	0.00163	CbGpPWpGaD
Thiabendazole—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—lung cancer	9.41e-05	0.00163	CbGpPWpGaD
Thiabendazole—Abdominal pain—Doxorubicin—lung cancer	9.35e-05	0.000736	CcSEcCtD
Thiabendazole—Diarrhoea—Methotrexate—lung cancer	9.35e-05	0.000736	CcSEcCtD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—MTMR3—lung cancer	9.12e-05	0.00158	CbGpPWpGaD
Thiabendazole—Dizziness—Methotrexate—lung cancer	9.03e-05	0.000711	CcSEcCtD
Thiabendazole—CYP1A2—Phase II conjugation—GSTM1—lung cancer	9.01e-05	0.00156	CbGpPWpGaD
Thiabendazole—CYP1A1—Biological oxidations—GSTP1—lung cancer	8.99e-05	0.00155	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—lung cancer	8.96e-05	0.00155	CbGpPWpGaD
Thiabendazole—CYP1A1—Metapathway biotransformation—GSTP1—lung cancer	8.87e-05	0.00153	CbGpPWpGaD
Thiabendazole—CYP1A2—Tryptophan metabolism—MDM2—lung cancer	8.85e-05	0.00153	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—lung cancer	8.82e-05	0.00152	CbGpPWpGaD
Thiabendazole—Hypersensitivity—Doxorubicin—lung cancer	8.72e-05	0.000686	CcSEcCtD
Thiabendazole—Vomiting—Methotrexate—lung cancer	8.69e-05	0.000684	CcSEcCtD
Thiabendazole—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—lung cancer	8.65e-05	0.0015	CbGpPWpGaD
Thiabendazole—Rash—Methotrexate—lung cancer	8.61e-05	0.000678	CcSEcCtD
Thiabendazole—Dermatitis—Methotrexate—lung cancer	8.61e-05	0.000677	CcSEcCtD
Thiabendazole—Headache—Methotrexate—lung cancer	8.56e-05	0.000674	CcSEcCtD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—lung cancer	8.53e-05	0.00148	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—HPGDS—lung cancer	8.53e-05	0.00147	CbGpPWpGaD
Thiabendazole—Asthenia—Doxorubicin—lung cancer	8.49e-05	0.000668	CcSEcCtD
Thiabendazole—Pruritus—Doxorubicin—lung cancer	8.37e-05	0.000659	CcSEcCtD
Thiabendazole—CYP1A2—Biological oxidations—GSTT1—lung cancer	8.27e-05	0.00143	CbGpPWpGaD
Thiabendazole—CYP1A1—Biological oxidations—GSTM1—lung cancer	8.27e-05	0.00143	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—CYP2A6—lung cancer	8.18e-05	0.00141	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—GCLC—lung cancer	8.18e-05	0.00141	CbGpPWpGaD
Thiabendazole—CYP1A1—Metapathway biotransformation—GSTM1—lung cancer	8.15e-05	0.00141	CbGpPWpGaD
Thiabendazole—CYP1A1—PPARA activates gene expression—CREBBP—lung cancer	8.14e-05	0.00141	CbGpPWpGaD
Thiabendazole—Nausea—Methotrexate—lung cancer	8.11e-05	0.000639	CcSEcCtD
Thiabendazole—Diarrhoea—Doxorubicin—lung cancer	8.09e-05	0.000637	CcSEcCtD
Thiabendazole—CYP1A2—Arachidonic acid metabolism—PTGS2—lung cancer	7.98e-05	0.00138	CbGpPWpGaD
Thiabendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CREBBP—lung cancer	7.96e-05	0.00138	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—lung cancer	7.91e-05	0.00137	CbGpPWpGaD
Thiabendazole—Dizziness—Doxorubicin—lung cancer	7.82e-05	0.000616	CcSEcCtD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—lung cancer	7.69e-05	0.00133	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—lung cancer	7.62e-05	0.00132	CbGpPWpGaD
Thiabendazole—Vomiting—Doxorubicin—lung cancer	7.52e-05	0.000592	CcSEcCtD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PLBD1—lung cancer	7.48e-05	0.00129	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—lung cancer	7.46e-05	0.00129	CbGpPWpGaD
Thiabendazole—Rash—Doxorubicin—lung cancer	7.46e-05	0.000587	CcSEcCtD
Thiabendazole—Dermatitis—Doxorubicin—lung cancer	7.45e-05	0.000586	CcSEcCtD
Thiabendazole—Headache—Doxorubicin—lung cancer	7.41e-05	0.000583	CcSEcCtD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—lung cancer	7.1e-05	0.00123	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—EP300—lung cancer	7.1e-05	0.00123	CbGpPWpGaD
Thiabendazole—Nausea—Doxorubicin—lung cancer	7.03e-05	0.000553	CcSEcCtD
Thiabendazole—CYP1A2—Phase 1 - Functionalization of compounds—POMC—lung cancer	7.01e-05	0.00121	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—CYP2E1—lung cancer	6.95e-05	0.0012	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—lung cancer	6.9e-05	0.00119	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—SRC—lung cancer	6.9e-05	0.00119	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—COL4A3BP—lung cancer	6.89e-05	0.00119	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—AZIN2—lung cancer	6.89e-05	0.00119	CbGpPWpGaD
Thiabendazole—CYP1A2—Metapathway biotransformation—CYP2E1—lung cancer	6.86e-05	0.00119	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—lung cancer	6.72e-05	0.00116	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—lung cancer	6.64e-05	0.00115	CbGpPWpGaD
Thiabendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—APOA1—lung cancer	6.48e-05	0.00112	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	6.43e-05	0.00111	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	6.22e-05	0.00108	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—MYC—lung cancer	6.18e-05	0.00107	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—lung cancer	6.05e-05	0.00105	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—lung cancer	6.05e-05	0.00105	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ATP5H—lung cancer	5.86e-05	0.00101	CbGpPWpGaD
Thiabendazole—CYP1A1—Biological oxidations—POMC—lung cancer	5.84e-05	0.00101	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—MTMR3—lung cancer	5.82e-05	0.00101	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—GSTP1—lung cancer	5.74e-05	0.000991	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—lung cancer	5.71e-05	0.000988	CbGpPWpGaD
Thiabendazole—CYP1A2—Metapathway biotransformation—GSTP1—lung cancer	5.66e-05	0.000978	CbGpPWpGaD
Thiabendazole—CYP1A1—PPARA activates gene expression—EP300—lung cancer	5.54e-05	0.000958	CbGpPWpGaD
Thiabendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CREBBP—lung cancer	5.49e-05	0.000949	CbGpPWpGaD
Thiabendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—lung cancer	5.42e-05	0.000938	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	5.39e-05	0.000931	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—GSTM1—lung cancer	5.27e-05	0.000911	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PLBD1—lung cancer	5.22e-05	0.000903	CbGpPWpGaD
Thiabendazole—CYP1A2—Metapathway biotransformation—GSTM1—lung cancer	5.2e-05	0.000899	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	5.14e-05	0.000888	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—CYP1A1—lung cancer	5e-05	0.000864	CbGpPWpGaD
Thiabendazole—CYP1A2—Metapathway biotransformation—CYP1A1—lung cancer	4.93e-05	0.000852	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—lung cancer	4.86e-05	0.00084	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—HSD17B10—lung cancer	4.78e-05	0.000826	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CKB—lung cancer	4.44e-05	0.000768	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—COL4A3BP—lung cancer	4.39e-05	0.00076	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—AZIN2—lung cancer	4.39e-05	0.00076	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GSTM2—lung cancer	4.18e-05	0.000722	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CNDP2—lung cancer	4.18e-05	0.000722	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	4.1e-05	0.000708	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—MTMR3—lung cancer	4.06e-05	0.000702	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	3.97e-05	0.000686	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PGAM1—lung cancer	3.96e-05	0.000684	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CYP2A7—lung cancer	3.78e-05	0.000653	CbGpPWpGaD
Thiabendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—lung cancer	3.74e-05	0.000646	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ATP5H—lung cancer	3.74e-05	0.000646	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—POMC—lung cancer	3.73e-05	0.000644	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—SDC4—lung cancer	3.7e-05	0.000639	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	3.43e-05	0.000594	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—RRM1—lung cancer	3.37e-05	0.000582	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GSTA3—lung cancer	3.37e-05	0.000582	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PLBD1—lung cancer	3.33e-05	0.000576	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	3.28e-05	0.000566	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—B4GALT5—lung cancer	3.16e-05	0.000547	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GSTA4—lung cancer	3.08e-05	0.000532	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—HSD17B10—lung cancer	3.05e-05	0.000527	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GSTA2—lung cancer	3e-05	0.000519	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GSTA1—lung cancer	2.89e-05	0.0005	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ABCC3—lung cancer	2.86e-05	0.000495	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CKB—lung cancer	2.83e-05	0.00049	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—AKR1C1—lung cancer	2.77e-05	0.000479	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—UGT1A1—lung cancer	2.69e-05	0.000465	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CNDP2—lung cancer	2.66e-05	0.00046	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GSTM2—lung cancer	2.66e-05	0.00046	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GNG11—lung cancer	2.59e-05	0.000449	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—MTMR3—lung cancer	2.59e-05	0.000448	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—APOA1—lung cancer	2.58e-05	0.000446	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PGAM1—lung cancer	2.52e-05	0.000436	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ALDOA—lung cancer	2.47e-05	0.000427	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CYP2A7—lung cancer	2.41e-05	0.000416	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—NCOA3—lung cancer	2.4e-05	0.000415	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	2.36e-05	0.000407	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—SDC4—lung cancer	2.36e-05	0.000407	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ADCY1—lung cancer	2.33e-05	0.000403	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ABCG2—lung cancer	2.33e-05	0.000403	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ENO2—lung cancer	2.29e-05	0.000396	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—HPGDS—lung cancer	2.29e-05	0.000396	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PPP2R1B—lung cancer	2.27e-05	0.000393	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—POMC—lung cancer	2.24e-05	0.000388	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GSTT1—lung cancer	2.22e-05	0.000384	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GCLC—lung cancer	2.19e-05	0.000379	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CYP2A6—lung cancer	2.19e-05	0.000379	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	2.19e-05	0.000378	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GSTA3—lung cancer	2.15e-05	0.000371	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—RRM1—lung cancer	2.15e-05	0.000371	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ENO1—lung cancer	2.08e-05	0.000359	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	2.07e-05	0.000358	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—ALB—lung cancer	2.05e-05	0.000354	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—B4GALT5—lung cancer	2.02e-05	0.000349	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GSTA4—lung cancer	1.96e-05	0.000339	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	1.92e-05	0.000332	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GSTA2—lung cancer	1.91e-05	0.000331	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CYP2E1—lung cancer	1.87e-05	0.000322	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GSTA1—lung cancer	1.85e-05	0.000319	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—NQO1—lung cancer	1.84e-05	0.000319	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ABCC3—lung cancer	1.82e-05	0.000315	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.81e-05	0.000312	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.79e-05	0.000309	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—AKR1C1—lung cancer	1.77e-05	0.000306	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—UGT1A1—lung cancer	1.72e-05	0.000297	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—STK11—lung cancer	1.66e-05	0.000287	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GNG11—lung cancer	1.65e-05	0.000286	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.65e-05	0.000285	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ALDOA—lung cancer	1.58e-05	0.000272	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.56e-05	0.00027	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GSTP1—lung cancer	1.54e-05	0.000266	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—NCOA3—lung cancer	1.53e-05	0.000264	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.5e-05	0.00026	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CAT—lung cancer	1.5e-05	0.000259	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.49e-05	0.000257	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ABCG2—lung cancer	1.49e-05	0.000257	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ADCY1—lung cancer	1.49e-05	0.000257	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ENO2—lung cancer	1.46e-05	0.000252	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—HPGDS—lung cancer	1.46e-05	0.000252	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ABCB1—lung cancer	1.46e-05	0.000252	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PPP2R1B—lung cancer	1.45e-05	0.000251	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.43e-05	0.000247	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—TYMS—lung cancer	1.43e-05	0.000247	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GSTT1—lung cancer	1.42e-05	0.000245	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GSTM1—lung cancer	1.41e-05	0.000244	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CYP2A6—lung cancer	1.4e-05	0.000242	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GCLC—lung cancer	1.4e-05	0.000242	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.39e-05	0.000241	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ERCC2—lung cancer	1.33e-05	0.00023	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ENO1—lung cancer	1.33e-05	0.000229	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.32e-05	0.000228	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.3e-05	0.000225	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CYP2E1—lung cancer	1.19e-05	0.000206	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—NQO1—lung cancer	1.18e-05	0.000203	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.15e-05	0.000199	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—APOA1—lung cancer	1.15e-05	0.000199	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.14e-05	0.000197	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.1e-05	0.00019	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—STK11—lung cancer	1.06e-05	0.000183	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PIK3CG—lung cancer	1.05e-05	0.000181	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—POMC—lung cancer	9.99e-06	0.000173	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	9.95e-06	0.000172	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GSTP1—lung cancer	9.81e-06	0.00017	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CREBBP—lung cancer	9.73e-06	0.000168	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CAT—lung cancer	9.54e-06	0.000165	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	9.49e-06	0.000164	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ABCB1—lung cancer	9.28e-06	0.00016	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PIK3CD—lung cancer	9.23e-06	0.00016	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—TYMS—lung cancer	9.12e-06	0.000158	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ALB—lung cancer	9.11e-06	0.000157	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GSTM1—lung cancer	9.01e-06	0.000156	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CYP1A1—lung cancer	8.54e-06	0.000148	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ERCC2—lung cancer	8.47e-06	0.000146	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PIK3CB—lung cancer	8.04e-06	0.000139	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PTGS2—lung cancer	7.97e-06	0.000138	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—APOA1—lung cancer	7.33e-06	0.000127	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	7.02e-06	0.000121	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PTEN—lung cancer	6.95e-06	0.00012	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PIK3CG—lung cancer	6.69e-06	0.000116	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—EP300—lung cancer	6.63e-06	0.000115	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—POMC—lung cancer	6.37e-06	0.00011	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CREBBP—lung cancer	6.21e-06	0.000107	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PIK3CD—lung cancer	5.88e-06	0.000102	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ALB—lung cancer	5.81e-06	0.0001	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PIK3CB—lung cancer	5.13e-06	8.86e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PTGS2—lung cancer	5.08e-06	8.78e-05	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PIK3CA—lung cancer	4.9e-06	8.48e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PTEN—lung cancer	4.43e-06	7.66e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—EP300—lung cancer	4.23e-06	7.31e-05	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—AKT1—lung cancer	4.01e-06	6.92e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PIK3CA—lung cancer	3.13e-06	5.4e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—AKT1—lung cancer	2.55e-06	4.41e-05	CbGpPWpGaD
